October 2020 PMID 32615369

Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression.

Yin-Gi Jang, Eul-Bee Ko, Kyung-Chul Choi

Download social card

Mentions

2
Peak: 1 in Jul 2020
across 2 sources since Jul 2020

Extended reach

34,947
potential audience

Total likes

657

Video views

34,056

Mentions per month

Jul 2020 – Jul 2025

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions highlight the promising nature of gallic acid as an anti-cancer agent, with posts emphasizing its potential to inhibit tumor growth by targeting HDACs, using supportive language like 'exciting' and 'potential breakthrough,' which reflects a generally optimistic and motivated tone about the research's significance.

AgreementStrong agreement

Most discussions express strong support or acknowledgment of the publication's significance, reflected in phrases like 'exciting research' and 'promising findings.'

InterestModerate interest

The overall interest is moderate, with some posts showing curiosity about the potential applications, though others are brief or neutral.

EngagementModerate engagement

Posts tend to engage with the content by mentioning specific mechanisms (e.g., inhibition of HDAC1/2) and potential therapeutic implications, indicating active but not deeply detailed discussions.

ImpactModerate impact

Participants acknowledge the potential impact of the research on prostate cancer treatment, suggesting that these findings could influence future therapies, although some posts remain speculative.

Abstract in brief

  • Gallic acid (GA) can inhibit prostate cancer progression by decreasing the expression of histone deacetylases HDAC1 and 2, which are often overexpressed in tumors and linked to poor prognosis.
  • GA selectively reduces the viability and tumor-forming abilities of prostate cancer cells, induces apoptosis, and affects cell cycle and apoptosis-related genes, unlike some other HDAC inhibitors that may impact normal cells.
  • In animal models, oral GA treatment decreases tumor size and structure, further supporting its potential as an anti-cancer therapy targeting HDACs in prostate cancer.

Top posts

Most liked on X and Bluesky
Paperbirds_Oncology
@PaperbirdsO · X

New article: Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. https://t.co/nfVQeBHlJT #prostatecancer #oncology https://t.co/kUYMMrxJDG

Jul 3, 2020 · 891 followers View post →

All mentions

Paperbirds_Oncology
@PaperbirdsO · X

New article: Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. https://t.co/nfVQeBHlJT #prostatecancer #oncology https://t.co/kUYMMrxJDG

Jul 3, 2020 · 891 followers View post →